Finance Home - Yahoo! - Help

Elan Corporation, PLC Earnings Conference Call (Q4 2004)  Today's Calls

Visit the CCBN Network· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Yahoo! Player Real Player 8 Basic Windows Media Player Other Conference Calls Other Feb 8 Calls Today's Calls

Call Details Elan Corporation, PLC Earnings Conference Call (Q4 2004) Scheduled to start Tue, Feb 8, 2005, 8:30 am Eastern Check back at the scheduled start time for the audio link to appear in this spot. Add This Event To Your Yahoo! Calendar After the event has finished, the audio will be available from this page until Thu, Feb 9, 2006 About Elan Corporation, PLC (NYSE:ELN) Other Calls  Elan Corporation, plc is a neuroscience-based biotechnology company that focuses on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases and severe pain. Elan markets two products in the United States: AZACTAM (aztreonam for injection, USP) and MAXIPIME (cefepime hydrochloride) for Injection. AZACTAM is a monobactam indicated for the treatment of the infections caused by susceptible gram-negative microorganisms and is principally used by surgeons, infectious disease specialists and internal medicine physicians to treat pneumonia, post-surgical infections and septicemia. MAXIPIME for Injection is a semi-synthetic, broad-spectrum, cephalosporin antibiotic used by pulmonologists, infectious disease specialists, internal medicine physicians, hematologists and oncologists to treat patients with serious and/or potentially life-threatening infections. More from Reuters: Expanded Business Description More Info: Quote | Chart | News | Profile | Reports | Research | Msgs | Insider | Financials